Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Sidoti & Co. Upgrades Staar Surgical to Buy

Sidoti & Co. Upgrades Staar Surgical to Buy

Sidoti & Co. analyst James Sidoti upgrades Staar Surgical (NASDAQ:STAA) from Neutral to Buy.

byBenzinga Newsdesk

November 7, 2022

1 minute read

Sidoti & Co. analyst James Sidoti upgrades Staar Surgical (NASDAQ:STAA) from Neutral to Buy.

Zoetis, NVIDIA And This Big US Bank Is ‘Outperforming This Year’: CNBC’s ‘Final Trades’

By Lisa Levin

February 15, 10:06 AM

On CNBC’s "Halftime Report Final Trades," Stephanie Link of Hightower said Zoetis Inc.

Spire Global Q2 EPS $(0.29) Misses $(0.12) Estimate, Sales $19.39M Beat $19.12M Estimate

By Benzinga Newsdesk

August 10, 4:22 PM

Spire Global (NYSE:SPIR) reported quarterly losses of $(0.29) per share which missed the analyst consensus estimate of $(0.12) by 141.67 percent. The company reported quarterly sales of $19.39 million which beat the

SPIR

Analyst Ratings

What 6 Analyst Ratings Have To Say About Triumph Financial

By Benzinga Insights

April 5, 1:01 PM

Analysts have provided the following ratings for Triumph Financial (NASDAQ:TFIN) within the last quarter: Bullish Somewhat Bullish Indifferent…

TFIN

EXCLUSIVE: NY Cannabis Market Optimism Prevails Despite ‘Absurd’ Taxes, Illegal Operators, Lawsuits

By Nina Zdinjak

September 28, 4:58 PM

Ever since the launch of the legal cannabis market in New York last year, the industry has been dealing with one setback after another.

ACRHF

Sidoti & Co. Upgrades Staar Surgical to Buy

Related Posts

Zoetis, NVIDIA And This Big US Bank Is ‘Outperforming This Year’: CNBC’s ‘Final Trades’

Spire Global Q2 EPS $(0.29) Misses $(0.12) Estimate, Sales $19.39M Beat $19.12M Estimate

What 6 Analyst Ratings Have To Say About Triumph Financial

EXCLUSIVE: NY Cannabis Market Optimism Prevails Despite ‘Absurd’ Taxes, Illegal Operators, Lawsuits